Suzuken Co (SSE:9987) Beneish M-Score: -2.40 (As of Jun. 26, 2026)

What is Suzuken Co Beneish M-Score?

Suzuken Co SSE:9987 77 Beneish M-Score is -2.40 as of Jun. 26, 2026. GuruFocus rates SSE:9987 with a GF Score™ of 77/100 and a GF Value™ of 円4,748.65. The stock has 1 warning sign investors should review. Among 113 Medical Distribution companies, Suzuken Co ranks worse than 60.18% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.4 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Suzuken Co's Beneish M-Score or its related term are showing as below:

SSE:9987' s Beneish M-Score Range Over the Past 10 Years
Min: -2.84 Med: -2.48 Max: -2.12
Current: -2.4

During the past 13 years, the highest Beneish M-Score of Suzuken Co was -2.12. The lowest was -2.84. And the median was -2.48.

Suzuken Co Beneish M-Score Related Terms

Suzuken Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Suzuken Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzuken Co Beneish M-Score Chart

Suzuken Co Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Beneish M-Score

Get a 7-Day Free Trial

-2.42

-2.54

-2.68

-2.12

-2.40

Suzuken Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Beneish M-Score	Get a 7-Day Free Trial															-2.12	0.00	0.00	0.00	-2.40

SSE:9987 vs MCK, COR, CAH: Beneish M-Score Comparison

For the Medical Distribution subindustry, Suzuken Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzuken Co Beneish M-Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Suzuken Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Suzuken Co's Beneish M-Score falls into.

Save Embed

77GF Score

Suzuken Co Ltd SSE:9987

Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Suzuken Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Suzuken Co for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 1.0227

0.528 * 1.0346

0.404 * 0.9907

0.892 * 1.0361

0.115 * 1.0192

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 1

4.679 * 0.003954

0.327 * 1.0119

-2.40

This Year (Mar26) TTM:

Last Year (Mar25) TTM:

Total Receivables was 円574,082 Mil.
Revenue was 円2,486,647 Mil.
Gross Profit was 円192,524 Mil.
Total Current Assets was 円876,172 Mil.
Total Assets was 円1,155,766 Mil.
Property, Plant and Equipment(Net PPE) was 円139,563 Mil.
Depreciation, Depletion and Amortization(DDA) was 円12,341 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円713,052 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.
Net Income was 円38,136 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円33,566 Mil.

Total Receivables was 円541,781 Mil.
Revenue was 円2,399,952 Mil.
Gross Profit was 円192,231 Mil.
Total Current Assets was 円844,099 Mil.
Total Assets was 円1,113,831 Mil.
Property, Plant and Equipment(Net PPE) was 円133,512 Mil.
Depreciation, Depletion and Amortization(DDA) was 円12,053 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円679,114 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(574082 / 2486647)	/	(541781 / 2399952)
	=	0.230866	/	0.225747
	=	1.0227

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(192231 / 2399952)	/	(192524 / 2486647)
	=	0.080098	/	0.077423
	=	1.0346

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (876172 + 139563) / 1155766)	/	(1 - (844099 + 133512) / 1113831)
	=	0.121159	/	0.122299
	=	0.9907

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	2486647	/	2399952
	=	1.0361

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(12053 / (12053 + 133512))	/	(12341 / (12341 + 139563))
	=	0.082801	/	0.081242
	=	1.0192

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(0 / 2486647)	/	(0 / 2399952)
	=	0	/	0
	=	1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 713052) / 1155766)	/	((0 + 679114) / 1113831)
	=	0.616952	/	0.60971
	=	1.0119

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(38136 - 0	-	33566)	/	1155766
	=	0.003954

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Suzuken Co has a M-score of -2.40 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →

What does a Beneish M-Score of -2.40 mean?

Suzuken Co (SSE:9987) has a Beneish M-Score of -2.40 as of Jun. 26, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Suzuken Co and its competitors. According to the industry distribution chart, Suzuken Co ranks #68 out of 113 companies in the Medical Distribution industry, placing it in the top 60.2%.

Is Suzuken Co's Beneish M-Score too high?

Suzuken Co's current Beneish M-Score is -2.40. Based on the distribution chart, Suzuken Co ranks #68 out of 113 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Suzuken Co has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.

How does Suzuken Co's Beneish M-Score compare to MCK and COR?

According to the Medical Distribution industry distribution chart, Suzuken Co ranks #68 out of 113 companies for Beneish M-Score. This places Suzuken Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Beneish M-Score for a Medical Distribution company?

A good Beneish M-Score depends on the Medical Distribution industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Beneish M-Score mean?

A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Suzuken Co and its competitors. Suzuken Co's current Beneish M-Score is -2.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Suzuken Co stock overvalued right now?

Suzuken Co (SSE:9987) has a current Beneish M-Score of -2.40. The stock's GF Value™ is 円4,748.65, compared to a current price of 円3,995.00 — trading 15.9% below its estimated fair value. The current Beneish M-Score is -2.40. Suzuken Co's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Beneish M-Score calculated?

Beneish M-Score is calculated from a company's financial statements. For Suzuken Co (SSE:9987), the current Beneish M-Score is -2.40 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzuken Co (SSE:9987) Overvalued in 2026?

Based on GuruFocus' analysis, Suzuken Co stock appears to be undervalued. The current stock price of 円3,995.00 is trading 15.9% below its estimated GF Value™ of 円4,748.65.

Key valuation signals for SSE:9987:

Beneish M-Score: -2.40
GF Value™: 円4,748.65 vs. price of 円3,995.00 (15.9% below fair value)
GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the SSE:9987 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suzuken Co Business Description

Industry Healthcare Medical Distribution

Comparable Companies TSE:2784 TSE:8129 TSE:7459 TSE:7476 TSE:3151 TSE:3183 NGO:7488 SSE:3055 TSE:7634 TSE:2689 MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998

Other Exchanges 9987:Japan ZU1:Germany

Address 8 Higashikatabatacho, Higashi Ward, Aichi Prefecture, Nagoya, JPN, 461-8701

Website https://www.suzuken.co.jp

Suzuken Co Ltd is engaged in the manufacture and sale of pharmaceuticals and medical devices, and in providing insurance, pharmacy, and nursing care services. The company operates through segments, including Pharmaceutical Wholesale business, Healthcare product development business, Specialty Pharmaceuticals Distribution business, Regional medical nursing care support business, and Medical-related Services business. It generates the majority of its revenue from the Pharmaceutical Wholesale Business segment, which sells prescription pharmaceuticals, diagnostic reagents, medical equipment, and medical supplies.

77GF Score

Get the complete analysis for SSE:9987

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円3,995.00

Price

円4,748.65

GF Value

View SSE:9987 Analysis

See Beneish M-Score data for all stocks →